project id: TCGA-LUAD; case submitter id: TCGA-44-7671; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; state: released; normal tumor genotype snp match: Yes; age at index: 64; days to birth: -23538; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1946; age at diagnosis: 23538; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 889.0; icd 10 code: C34.2; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Middle lobe, lung; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; oct embedded: No; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;